The revolution of the anti-diabetic drugs in cardiology
暂无分享,去创建一个
[1] L. Cho,et al. Cardioprotective anti-hyperglycaemic medications: a review of clinical trials , 2018, European heart journal.
[2] Lawrence A Leiter,et al. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum , 2017, Diabetes Care.
[3] K. Mahaffey,et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.
[4] Lawrence A Leiter,et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.
[5] John B Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[6] E. Ferrannini,et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis , 2016, Diabetes Care.
[7] E. Orsi,et al. Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1 year of Liraglutide treatment. , 2016, Metabolism: clinical and experimental.
[8] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.
[9] I. Tikkanen,et al. Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension , 2014, Diabetes Care.
[10] A. Tahrani,et al. SGLT inhibitors in management of diabetes. , 2013, The lancet. Diabetes & endocrinology.
[11] D. Drucker,et al. The safety of incretin-based therapies--review of the scientific evidence. , 2011, The Journal of clinical endocrinology and metabolism.
[12] Y. Lee,et al. Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells. , 2007, Kidney international. Supplement.
[13] D. Drucker,et al. Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.
[14] Chari D Smith,et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. , 2005, Diabetes.